YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novartis to buy cancer-drug maker for $2B

Posted online

Novartis AG announced it would purchase Endocyte Inc. for $2.1 billion.

The acquisition would give the Swiss pharmaceutical company access to Endocyte's so-called radiopharmaceuticals, which carry radioactive substances to kill tumor cells.

Endocyte is currently developing a new treatment for prostate cancer.

Read more from The Wall Street Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open for Business: Show Me Chuy

April 7 was the official opening day for Mexican-Italian fusion restaurant Show Me Chuy after a soft launch that started March 31; marketing agency AdZen debuted; and the Almighty Sando Shop opened a brick-and-mortar space.

Most Read
SBJ.net Poll
Update cookies preferences